Is DOCS stock a Buy, Sell, or Hold?

Based on our analysis, DOCS is currently a HOLD with moderate confidence. 📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of DOCS stock?

Our analysis estimates the fair value range for DOCS to be between $23.39 and $26.72. The current price is $25.58.

What is the analyst price target for DOCS?

The average Wall Street analyst price target for DOCS is $29.94. This implies a potential upside of 17.1% from current levels.

Doximity (DOCS) Stock: Buy, Sell, or Hold?

DOCS - Doximity, Inc.

SERVICES-COMPUTER PROGRAMMING SERVICES

$25.58

0.87 (3.52%) ▲

5d: -5.61%

30d: +2.36%

90d: +27.77%

HOLD

MODERATE Confidence

Protect Your DOCS Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Aug 06, 2026 0d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 8, 2026 at $24.90 · last confirmed Sep 11, 2026

Strength: 6.9/10

Get Alerted When DOCS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 4.8%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$35.18

Based on 4.4% avg growth

INTRINSIC VALUE TODAY

$21.84

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: DOCS is currently trading at $25.58, which is considered fair relative to its 30-day fair value range of $23.39 to $26.72. The stock's valuation (Forward PE: 15.8) is in line with its historical norms (17.5). Remarkably, the market is currently pricing in an annual earnings decline of 3.4% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $23.95, while resistance sits at $27.32. The stock is showing strong short-term momentum, up 3.5% recently.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $29.94 (+17.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR

Historical Trading Range $23.39 - $26.72

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 74.8%

Protect Your Profits

Holding DOCS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Price in fair range
NEUTRAL: Mixed technical signals (40/100)
BULLISH: High volume confirmation
BULLISH: Strong upward momentum (+3.5%)
BULLISH: Trading below Wall St target ($29.94)
NEUTRAL: Bottoming setup forming (40/100) — watch for confirmation
CAUTION: 5-day price weakness (-5.6%) - monitor closely

Trading Range Analysis

30-Day Trading Range $23.39 - $26.72

Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $23.96

Resistance Level $27.32

Current Trend Strong Uptrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 15.78

Wall Street Target $29.94 (+17.1%)

Revenue Growth (YoY) 7.3%

Earnings Growth (YoY) -51.9%

Profit Margin 25.5%

Valuation Discount vs History -3.4% cheaper

PE vs Historical 15.8 vs 17.5 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -3.4% (market-implied from PE analysis)

1-Year Target $24.71 (-3%)

2-Year Target $23.87 (-7%)

3-Year Target $23.06 (-10%)

3-Yr Target (if PE normalizes) (PE: 16→18) $25.57 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: 4.8%) $37.62 (+47%)

Base: (SPY PE: 15.8, Growth: 4.8%) $29.44 (+15%)

Bear: (PE: 13.4, Growth: 4.8%) $25.02 (-2%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (16x PE) as earnings recover.

Trailing PE: 28.73 | Current EPS (TTM): $0.86

Bull Case $51.22 (+100%)

Analyst growth 88.5%, PE expands to 31.6

Base Case $46.57 (+82%)

Market implied 88.5%, PE stable at 28.7

Bear Case $16.80 (-34%)

Severe decline -20.0%, PE contracts to 24.4

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 15.8 to 17.5

Stabilization Target: $28.36 (+10.9%)

PE Expansion Potential: +10.9%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 11, 2026 7:08 PM ET
Data refreshes hourly during market hours. Next update: 8:08 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is DOCS showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Siddharth Sitaram SELL 2427 shares 2026-04-10

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for DOCS.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
VEEV Veeva Systems Inc Class A	BUY 32 analysts	$294	39 SELL
PRVA Privia Health Group Inc	STRONG BUY 21 analysts	$32	42 HOLD
GEHC GE HealthCare Technologi…	STRONG BUY 21 analysts	$90	49 HOLD
PHR Phreesia Inc	STRONG BUY 15 analysts	$14	51 HOLD
WAY Waystar Holding Corp. Co…	STRONG BUY 13 analysts	$33	45 HOLD

VEEV Veeva Systems Inc…

39 SELL

PRVA Privia Health Gro…

42 HOLD

GEHC GE HealthCare Tec…

49 HOLD

PHR Phreesia Inc

51 HOLD

WAY Waystar Holding C…

45 HOLD

Advanced DOCS Option Strategies

Professional options setups generated by AI based on today's DOCS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for DOCS

DOCS Technical Chart DOCS Price Prediction DOCS Earnings Date Why is DOCS Moving Today? DOCS Investment Advisor DOCS Fair Price Analyzer DOCS Options Advisor DOCS Options Chain DOCS Options Analysis DOCS Competitors

Compare DOCS with Peers

DOCS vs DOCN
Which one to buy?

DOCS vs MQ
Which one to buy?

DOCS vs GLBE
Which one to buy?

DOCS vs ASAN
Which one to buy?

DOCS vs MNDY
Which one to buy?

SVRE vs DOCS
Winner: Tie

TXG vs DOCS

LZMH vs DOCS

DOCS vs CERT

KD vs DOCS
Winner: DOCS

XTIA vs DOCS

FIGS vs DOCS
Winner: DOCS

ELWS vs DOCS

MQ vs DOCS

DAVA vs DOCS

Create New Comparison View All Competitors

Tradestie